RU2016147198A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016147198A3 RU2016147198A3 RU2016147198A RU2016147198A RU2016147198A3 RU 2016147198 A3 RU2016147198 A3 RU 2016147198A3 RU 2016147198 A RU2016147198 A RU 2016147198A RU 2016147198 A RU2016147198 A RU 2016147198A RU 2016147198 A3 RU2016147198 A3 RU 2016147198A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305179.3 | 2010-02-23 | ||
| EP10305179 | 2010-02-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012140421/15A Division RU2012140421A (ru) | 2010-02-23 | 2011-02-23 | Лекарственные формы для пероральной доставки адсорбентов в кишечник |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016147198A RU2016147198A (ru) | 2018-06-01 |
| RU2016147198A3 true RU2016147198A3 (ru) | 2018-06-01 |
| RU2681315C2 RU2681315C2 (ru) | 2019-03-06 |
Family
ID=42357439
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012140421/15A RU2012140421A (ru) | 2010-02-23 | 2011-02-23 | Лекарственные формы для пероральной доставки адсорбентов в кишечник |
| RU2016147198A RU2681315C2 (ru) | 2010-02-23 | 2016-12-01 | Лекарственные формы для пероральной доставки адсорбентов в кишечник |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012140421/15A RU2012140421A (ru) | 2010-02-23 | 2011-02-23 | Лекарственные формы для пероральной доставки адсорбентов в кишечник |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US9968562B2 (ru) |
| EP (1) | EP2538930B1 (ru) |
| JP (1) | JP5645975B2 (ru) |
| KR (1) | KR101820374B1 (ru) |
| CN (1) | CN102869351B (ru) |
| AU (1) | AU2011219788B2 (ru) |
| BR (1) | BR112012021275B1 (ru) |
| CA (1) | CA2790811C (ru) |
| CY (1) | CY1117869T1 (ru) |
| ES (1) | ES2586135T3 (ru) |
| HR (1) | HRP20160834T1 (ru) |
| HU (1) | HUE029299T2 (ru) |
| IL (1) | IL221542A (ru) |
| LT (1) | LT2538930T (ru) |
| MX (1) | MX340822B (ru) |
| PL (1) | PL2538930T3 (ru) |
| PT (1) | PT2538930T (ru) |
| RS (1) | RS54991B1 (ru) |
| RU (2) | RU2012140421A (ru) |
| SI (1) | SI2538930T1 (ru) |
| WO (1) | WO2011104275A1 (ru) |
| ZA (1) | ZA201207068B (ru) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20160834T1 (hr) * | 2010-02-23 | 2016-09-23 | Da Volterra | Formulacije za oralnu dopremu adsorbensa u crijevo |
| KR101890959B1 (ko) | 2010-11-04 | 2018-08-22 | 알비레오 에이비 | 간질환 치료를 위한 ｉｂａｔ 억제제 |
| CN102432737B (zh) * | 2011-09-07 | 2015-02-25 | 张绍国 | 一种缓释肠溶丙烯酸树脂乳胶液及其制法 |
| GB201204696D0 (en) | 2012-03-16 | 2012-05-02 | Ucl Business Plc | Therapy |
| ES2801801T3 (es) * | 2012-09-21 | 2021-01-13 | Ferring Bv | Composición farmacéutica |
| RU2015140610A (ru) * | 2013-03-14 | 2017-04-17 | ТЕРАБАЙОМ, ЭлЭлСи | Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств |
| WO2014154677A1 (en) * | 2013-03-25 | 2014-10-02 | Ferring Bv | Composition for the treatment of disease |
| CN106659726A (zh) | 2014-06-25 | 2017-05-10 | Ea制药株式会社 | 固体制剂及其着色防止或着色减少方法 |
| JP7029391B2 (ja) * | 2015-10-06 | 2022-03-03 | ダ・ボルテラ | Ｃｌｏｓｔｒｉｄｉｕｍ細菌の病原性又は毒性の抑制又は低減 |
| WO2017073531A1 (ja) * | 2015-10-26 | 2017-05-04 | 第一三共株式会社 | 多孔質材料の大腸または小腸下部へのデリバリー製剤 |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| WO2017138878A1 (en) * | 2016-02-09 | 2017-08-17 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10786529B2 (en) * | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| KR101884520B1 (ko) * | 2016-07-29 | 2018-08-02 | 한국식품연구원 | 벤토나이트를 유효성분으로 포함하는 염증성 장 질환의 예방 또는 치료용 약학적 조성물 |
| KR102106477B1 (ko) * | 2017-01-12 | 2020-05-06 | 차장옥 | 콕시듐증 예방 또는 치료용 조성물, 이의 제조방법 및 이의 이용 |
| CA3071285A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| SG11202012151XA (en) | 2018-06-20 | 2021-01-28 | Albireo Ab | Crystal modifications of odevixibat |
| KR20210040997A (ko) * | 2018-08-05 | 2021-04-14 | 다 볼떼라 | 항암제 효능의 개선 방법 |
| CN112689506A (zh) | 2018-08-05 | 2021-04-20 | 达·沃尔泰拉公司 | 用于治疗移植物抗宿主疾病的组合物 |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| WO2021034727A1 (en) * | 2019-08-16 | 2021-02-25 | Applied Molecular Transport Inc. | Compositions, formulations, and interleukin production and purification |
| CA3174395A1 (en) | 2020-04-03 | 2021-10-07 | Larry D. SUTTON | Enteric aerobization therapy |
| RU2747401C1 (ru) * | 2020-06-22 | 2021-05-04 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный университет" | Способ получения фармацевтических лекарственных форм на основе сополимеров метилметакрилата |
| WO2022084550A1 (en) | 2020-10-23 | 2022-04-28 | Da Volterra | Compositions for use in the treatment or prevention of dysbiosis |
| WO2022090433A1 (en) | 2020-10-30 | 2022-05-05 | Da Volterra | Method for the manufacture of an adsorbent formulation |
| WO2022101267A2 (en) | 2020-11-12 | 2022-05-19 | Da Volterra | Compositions for delivery of an adsorbent |
| WO2022101269A1 (en) | 2020-11-13 | 2022-05-19 | Da Volterra | Formulations and dosage regimen for oral delivery of adsorbents in the gut |
| WO2023056256A1 (en) | 2021-09-29 | 2023-04-06 | Lpoxy Therapeutics, Inc. | Enteric aerobization therapy |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3917821A (en) | 1973-10-23 | 1975-11-04 | Milton Manes | Palatable activated carbon |
| US4761284A (en) * | 1977-12-27 | 1988-08-02 | Kureha Kagaku Kogy Kabushiki Kaisha | Antidote including activated carbon particles |
| JPS5542210A (en) * | 1978-09-12 | 1980-03-25 | Koichi Ogawa | Special activated carbon |
| JPS62168540A (ja) * | 1986-01-21 | 1987-07-24 | Freunt Ind Co Ltd | 被覆方法 |
| US5356625A (en) | 1986-08-28 | 1994-10-18 | Enzacor Properties Limited | Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| WO1988001506A1 (en) * | 1986-08-28 | 1988-03-10 | Thomas Ko Sai Ying | Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| US5597564A (en) * | 1986-08-28 | 1997-01-28 | Enzacor Properties Limited | Method of administering a microgranular preparation to the intestinal region of animals |
| GB8812490D0 (en) | 1988-05-26 | 1988-06-29 | Agricultural & Food Res | Delayed release formulations |
| JPH03120227A (ja) | 1989-10-02 | 1991-05-22 | Shigeo Ochi | 飲食物消化分解産物吸収抑制剤 |
| IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
| JP3338119B2 (ja) * | 1993-04-14 | 2002-10-28 | 呉羽化学工業株式会社 | 抗糖尿病剤 |
| US5827497A (en) | 1996-08-14 | 1998-10-27 | Mayo Foundation For Medical Education And Research | Charcoal-radionuclide agents for measurement of gastrointestinal transit |
| FR2780052B1 (fr) | 1998-06-23 | 2000-07-21 | Ceca Sa | Agglomerats a base de charbon actif leur procede de preparation et leur utilisation comme agents d'adsorption |
| EP1284930A4 (en) | 2000-04-21 | 2004-07-28 | Watervisions Int Inc | FORMATION OF COMPOSITE MATERIALS WITH EXPANDABLE MATERIALS |
| US20020098553A1 (en) * | 2001-01-19 | 2002-07-25 | Pierre-Etienne Bost | Process for producing carrageenan with reduced amount of insoluble material |
| CA2344910C (en) * | 2001-04-23 | 2009-07-07 | Kureha Chemical Industry Co., Ltd. | Method for treating renal disease, and pharmaceutical composition for treating renal disease |
| EP1306128A1 (en) * | 2001-10-29 | 2003-05-02 | Tenaxis Gmbh | Sorptive composite materials |
| JP4486300B2 (ja) | 2002-07-25 | 2010-06-23 | ユニ・チャーム株式会社 | 吸収性物品のトップシート |
| FR2843302B1 (fr) | 2002-08-09 | 2004-10-22 | Centre Nat Rech Scient | Forme galenique pour la delivrance colique de principes actifs |
| JP3585043B2 (ja) * | 2003-01-22 | 2004-11-04 | メルク・ホエイ株式会社 | 医薬用吸着剤及びその製法 |
| WO2004096243A1 (ja) * | 2003-04-25 | 2004-11-11 | Kouki Bussan Yugenkaisha | 便秘予防および改善剤 |
| GB2405343A (en) | 2003-08-29 | 2005-03-02 | Johnson & Johnson Medical Ltd | Charcoal Wound Dressings |
| JP4409245B2 (ja) * | 2003-10-20 | 2010-02-03 | 株式会社荏原製作所 | 耐食性及び耐摩耗性を有する被覆用合金を用いた装置 |
| CN1615908B (zh) | 2003-10-22 | 2011-09-28 | 株式会社吴羽 | 口服给药用吸附剂、以及肾病治疗或预防剂、和肝病治疗或预防剂 |
| TWI370012B (en) * | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| JP5537762B2 (ja) | 2004-06-07 | 2014-07-02 | 株式会社クレハ | 乾燥形態の用時調製経口摂取用組成物及びゲル状経口摂取用組成物 |
| US9308176B2 (en) * | 2004-10-15 | 2016-04-12 | Supernus Pharmaceuticals, Inc | Less abusable pharmaceutical preparations |
| US9149439B2 (en) * | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
| WO2006122835A1 (en) * | 2005-05-18 | 2006-11-23 | Da Volterra | Colonic delivery of adsorbents |
| MX2008005932A (es) * | 2005-11-07 | 2008-12-17 | Perque Llc | Composiciones para regular trastornos intestinales y metodos de uso de las mismas. |
| US8557274B2 (en) * | 2005-12-06 | 2013-10-15 | Purdue Research Foundation | Slowly digesting starch and fermentable fiber |
| EP1957090A1 (en) | 2005-12-06 | 2008-08-20 | Ocera Therapeutics Inc. | Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome |
| DE102005062160A1 (de) * | 2005-12-19 | 2007-06-21 | BLüCHER GMBH | Aktivkohle für die medizinische Verwendung |
| US8048413B2 (en) * | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| WO2008021486A1 (en) * | 2006-08-17 | 2008-02-21 | Ocera Therapeutics, Inc. | Use of adsborbent carbon microspheres (ast-120) to treat gastroesophogeal reflux disease or symptoms thereof |
| DE202006016898U1 (de) * | 2006-10-12 | 2007-11-22 | BLüCHER GMBH | Hochleistungsadsorbentien auf der Basis von Aktivkohle mit hoher Mikroporosität |
| EP2081557A1 (en) * | 2006-11-17 | 2009-07-29 | DA Volterra | Colonic delivery using zn/pectin beads with a eudragit coating. |
| WO2008073517A1 (en) * | 2006-12-07 | 2008-06-19 | Ehrenpreis Eli D | Treatment for intestinal gas, bloating, microscopic colitis and traveler's diarrhea using colloidal bismuth subcitrate |
| WO2008084676A1 (ja) * | 2006-12-26 | 2008-07-17 | Medrx Co., Ltd. | 多孔性乾燥マトリックスの医薬組成物 |
| DE102007009242A1 (de) | 2007-02-22 | 2008-09-18 | Evonik Röhm Gmbh | Pellets mit magensaftresistenter Wirkstoff-Matix |
| US20090148538A1 (en) * | 2007-10-12 | 2009-06-11 | Ocera Therapeutics, Inc. | Use of adsorbent carbon microspheres to treat pouchitis |
| DE102008014109A1 (de) | 2008-03-13 | 2009-09-17 | Bayer Animal Health Gmbh | Suspensionsformulierung für Kohlenstoff-Adsorbentien |
| KR20100001892A (ko) | 2008-06-27 | 2010-01-06 | 주식회사 에코비젼 | 핵입자를 함유하는 질산화 미생물의 그래뉼 및 질산화미생물의 그래뉼화 촉진방법 |
| FR2950252B1 (fr) | 2009-09-23 | 2012-01-20 | Centre Nat Rech Scient | Forme galenique capable d'adsorber de maniere specifique les molecules indesirables |
| HRP20160834T1 (hr) * | 2010-02-23 | 2016-09-23 | Da Volterra | Formulacije za oralnu dopremu adsorbensa u crijevo |
-
2011
- 2011-02-23 HR HRP20160834TT patent/HRP20160834T1/hr unknown
- 2011-02-23 AU AU2011219788A patent/AU2011219788B2/en not_active Ceased
- 2011-02-23 PL PL11704468.5T patent/PL2538930T3/pl unknown
- 2011-02-23 BR BR112012021275-3A patent/BR112012021275B1/pt not_active IP Right Cessation
- 2011-02-23 PT PT117044685T patent/PT2538930T/pt unknown
- 2011-02-23 JP JP2012554336A patent/JP5645975B2/ja not_active Expired - Fee Related
- 2011-02-23 CA CA2790811A patent/CA2790811C/en active Active
- 2011-02-23 EP EP11704468.5A patent/EP2538930B1/en active Active
- 2011-02-23 RU RU2012140421/15A patent/RU2012140421A/ru unknown
- 2011-02-23 RS RS20160607A patent/RS54991B1/sr unknown
- 2011-02-23 WO PCT/EP2011/052682 patent/WO2011104275A1/en not_active Ceased
- 2011-02-23 KR KR1020127025014A patent/KR101820374B1/ko not_active Expired - Fee Related
- 2011-02-23 CN CN201180010736.1A patent/CN102869351B/zh not_active Expired - Fee Related
- 2011-02-23 ES ES11704468.5T patent/ES2586135T3/es active Active
- 2011-02-23 HU HUE11704468A patent/HUE029299T2/en unknown
- 2011-02-23 LT LTEP11704468.5T patent/LT2538930T/lt unknown
- 2011-02-23 MX MX2012009728A patent/MX340822B/es active IP Right Grant
- 2011-02-23 US US13/580,144 patent/US9968562B2/en active Active
- 2011-02-23 SI SI201130905A patent/SI2538930T1/sl unknown
-
2012
- 2012-08-20 IL IL221542A patent/IL221542A/en active IP Right Grant
- 2012-09-20 ZA ZA2012/07068A patent/ZA201207068B/en unknown
-
2016
- 2016-07-29 CY CY20161100748T patent/CY1117869T1/el unknown
- 2016-12-01 RU RU2016147198A patent/RU2681315C2/ru active
-
2017
- 2017-07-05 US US15/641,665 patent/US10052288B2/en active Active
-
2018
- 2018-07-26 US US16/046,501 patent/US11202761B2/en active Active
-
2021
- 2021-11-11 US US17/524,467 patent/US20220087945A1/en not_active Abandoned